Znn3bq.jpeg
²é¿´: 319  |  »Ø¸´: 0

TAINST

Ìú³æ (ÕýʽдÊÖ)

[½»Á÷] ¸³ÐμÁµÄÈÈ·ÖÎö·½·¨

Excipients are the components of a pharmaceutical formulation other than the active ingredient. Their purity, stability and other physical characteristics must be qualified along with those of the active component. Drug analysis methodology is often reported for excipients since these materials are universally available, and publication does not present an appearance of revealing trade secrets. Thermal analysis methods of drug analysis are reviewed and it is shown how DSC TzeroTM Technology improves the results. Detecting and characterizing polymorphs and pseudo-polymorphs and the characterization of amorphous formulations are described.
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : ¸³ÐμÁµÄÈÈ·ÖÎö·½·¨.pdf
  • 2017-01-11 10:46:22, 565.6 K

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ TAINST µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 291Çóµ÷¼Á +5 ¹ØÒä±±. 2026-04-11 5/250 2026-04-11 21:21 by lbsjt
[¿¼ÑÐ] ҩѧר˶µ÷¼Á +8 ? һ·Éú?»¨? 2026-04-10 10/500 2026-04-11 21:21 by zhouxiaoyu
[¿¼ÑÐ] µç×ÓÐÅÏ¢270Çóµ÷¼Á +14 terminal469 2026-04-07 14/700 2026-04-11 19:44 by laoshidan
[¿¼ÑÐ] 269Çóµ÷¼Á +11 °¡°¡ÎÒÎÒ 2026-04-07 11/550 2026-04-11 16:45 by vgtyfty
[¿¼ÑÐ] 283Çóµ÷¼Á 086004¿¼Ó¢¶þÊý¶þ +17 ÄǸöàà×Ó 2026-04-10 18/900 2026-04-11 16:27 by Ã÷Ô´ËʱÓÐ
[¿¼ÑÐ] ¹¤¿Æ273µ÷¼Á +6 X1999 2026-04-09 7/350 2026-04-11 10:23 by zhq0425
[¿¼ÑÐ] 275Çóµ÷¼Á +9 1624447980 2026-04-08 10/500 2026-04-11 10:20 by Delta2012
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] 326Çóµ÷¼Á +5 Shansyn 2026-04-10 5/250 2026-04-10 22:23 by Öí»á·É
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé +8 ÏàÐűػá¹ââÍòÕ 2026-04-07 9/450 2026-04-10 21:03 by zhouxiaoyu
[¿¼ÑÐ] 362Çóµ÷¼Á +10 ÎÒÒª¿¼´ó 2026-04-06 14/700 2026-04-10 17:00 by luoyongfeng
[¿¼ÑÐ] 085404 298·ÖÇóµ÷¼Á +10 ºôÀ²ºôÀ²ºôºôºô 2026-04-10 11/550 2026-04-10 16:44 by wangy0907
[¿¼ÑÐ] 266Çóµ÷¼Á +29 ÑôÑôÍÛÈû 2026-04-07 29/1450 2026-04-10 16:20 by ¸ßά´º
[¿¼ÑÐ] Ò»Ö¾Ô¸Öпƴó070300»¯Ñ§£¬314·ÖÇóµ÷¼Á +12 wakeluofu 2026-04-09 12/600 2026-04-10 09:57 by liuhuiying09
[¿¼ÑÐ] 301Çóµ÷¼Á +6 ¾²¾²ÏëÏë 2026-04-05 6/300 2026-04-10 09:15 by Delta2012
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©273Çóµ÷¼Á +18 ÀóÌâÄÏǽ 2026-04-05 19/950 2026-04-10 08:14 by kangsm
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á£¬Ò»Ö¾Ô¸Î÷ÄÏ´óѧ348£¬TopÆÚ¿¯Ò»Çø¶þ×÷¡¢¶þÇøÈý×÷£¬ÈýµÈ½±Ñ§½ðÈý´Î +4 candyyyi 2026-04-09 4/200 2026-04-09 18:39 by l_paradox
[¿¼ÑÐ] 287Çóµ÷¼Á +6 Fnhc 2026-04-07 6/300 2026-04-08 10:05 by xingguangj
[¿¼ÑÐ] »úеµ÷¼Á +3 zzzbcb 2026-04-07 3/150 2026-04-07 22:19 by hemengdong
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£© +5 ÐÇÐDz»Õ£ÑÛà¶ 2026-04-05 6/300 2026-04-07 22:16 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û